Melphalan HCl
Showing 1 - 25 of 1,079
Hematological Malignancy, Leukemia, Multiple Myeloma Trial in Milwaukee (Evomela, Fludarabine, Total Body Irradiation)
Recruiting
- Hematological Malignancy
- Multiple Myeloma
- Evomela
- +2 more
-
Milwaukee, WisconsinFroedtert Hospital & the Medical College of Wisconsin
Oct 4, 2022
Multiple Myeloma Trial in Kansas City (Melphalan HCL for Injection (Propylene Glycol-Free)/Alkeran for Injection, Alkeran for
Completed
- Multiple Myeloma
- Melphalan HCL for Injection (Propylene Glycol-Free)/Alkeran for Injection
- Alkeran for Injection/Melphalan HCL for Injection (Propylene Glycol-Free)
-
Kansas City, KansasUniversity of Kansas Medical Center/University of Kansas Cancer
Dec 9, 2019
Multiple Myeloma Trial in United States (High-Dose Melphalan HCL for Injection (Propylene Glycol-Free), Autologous
Completed
- Multiple Myeloma
- High-Dose Melphalan HCL for Injection (Propylene Glycol-Free)
- Autologous Transplantation
-
Chicago, Illinois
- +5 more
Apr 15, 2020
Taste Function In Multiple Myeloma Patients Undergoing
Active, not recruiting
- Multiple Myeloma
- Oral microbiota assessment
- +3 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jan 23, 2023
Multiple Myeloma Trial in Milwaukee (Melphalan HCl for injection (propylene glycol free))
Completed
- Multiple Myeloma
- Melphalan HCl for injection (propylene glycol free)
-
Milwaukee, WisconsinFroedtert Hospital and the Medical College of Wisconsin
Sep 12, 2018
Allogeneic Hematopoietic Stem Cell Transplantation, Allogeneic Stem Cell Transplantation, Hematologic Malignancies Trial in
Not yet recruiting
- Allogeneic Hematopoietic Stem Cell Transplantation
- +2 more
- Fludarabine
- +2 more
-
Orange, CaliforniaChao Family Comprehensive Cancer Center, University of Californi
Aug 31, 2023
Multiple Myeloma Trial in Hackensack (Thalidomide+Melphalan +Bortezomib+stem cell transplant)
Completed
- Multiple Myeloma
- Thalidomide+Melphalan +Bortezomib+stem cell transplant
-
Hackensack, New JerseyJohn Theurer Cancer Center at Hackensack University Medical Cent
Dec 16, 2022
Advanced Solid Tumor Trial (ZG0895 Hydrochloride for Injection)
Not yet recruiting
- Advanced Solid Tumor
- ZG0895 Hydrochloride for Injection
- (no location specified)
May 25, 2023
Plasma Cell Myeloma Trial in Israel, United States (Laboratory Biomarker Analysis, Lenalidomide, Melphalan)
Active, not recruiting
- Plasma Cell Myeloma
- Laboratory Biomarker Analysis
- +5 more
-
Mobile, Alabama
- +392 more
Jan 25, 2023
Local Anesthetic Complication Trial in Ankara (Articaine Hydrochloride + Epinephrine, Lidocaine Hydrochloride + Epinephrine)
Recruiting
- Local Anesthetic Complication
- Articaine Hydrochloride + Epinephrine
- Lidocaine Hydrochloride + Epinephrine
-
Ankara, TurkeyAnkara Yıldırım beyazıt University, Faculty of Dentistry
Aug 30, 2023
Recurrent Acute Leukemia of Ambiguous Lineage, Recurrent Acute Lymphoblastic Leukemia, Recurrent Acute Myeloid Leukemia Trial in
Completed
- Recurrent Acute Leukemia of Ambiguous Lineage
- +5 more
- Chemosensitivity Assay
- +4 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jun 29, 2022
Type1 Diabetes Trial in United States (HCL, verapamil 120mg tablet, non-HCL)
Completed
- Type1 Diabetes
- HCL
- +3 more
-
Palo Alto, California
- +5 more
Oct 31, 2022
Postoperative Pain, Cesarean Section Trial in Charlotte (Liposomal bupivacaine, Bupivacaine HCl)
Suspended
- Postoperative Pain
- Cesarean Section
- Liposomal bupivacaine
- Bupivacaine HCl
-
Charlotte, North CarolinaAtrium Health
Jan 27, 2023
Newly Diagnosed Multiple Myeloma Trial in Germany (Isatuximab, Lenalidomide, Bortezomib)
Not yet recruiting
- Newly Diagnosed Multiple Myeloma
- Isatuximab
- +4 more
-
Hamburg, Germany
- +3 more
Dec 16, 2022
Acute Myeloid Leukemia, Adult, Myelodysplastic Syndrome(MDS), Allogeneic Hematopoietic Stem Cell Transplantation Trial in Wuhan
Recruiting
- Acute Myeloid Leukemia, Adult
- +2 more
- Fludarabine and Busulfan
- Fludarabine and Melphalan
-
Wuhan, Hubei, ChinaWuhan Union Hospital, Tongji Medical college, Huazhong Universit
Jan 5, 2023
Multiple Myeloma Trial in Wuhan (Total Marrow irradiation,TMI, Autologous hematopoietic stem cell transplantation)
Recruiting
- Multiple Myeloma
- Total Marrow irradiation，TMI
- Autologous hematopoietic stem cell transplantation
-
Wuhan, Hubei, ChinaZhongnan Hospital of Wuhan University
Jul 24, 2023
NHWD-870 in Advanced Solid Tumors or Lymphomas Carrying NUT
Recruiting
- Advanced Solid Tumors or Lymphomas
-
Changsha, Hunan, ChinaHunan Provincal Tumor Hospital
Oct 5, 2023
Multiple Myeloma Trial in Saint Louis (Uproleselan, Placebo, Melphalan)
Completed
- Multiple Myeloma
- Uproleselan
- +2 more
-
Saint Louis, MissouriWashington University School of Medicine
Nov 22, 2022
Hairy Cell Leukemia Trial run by the NCI (Moxetumomab Pasudotox-tdfk, Rituximab, Ruxience)
Active, not recruiting
- Hairy Cell Leukemia
- Moxetumomab Pasudotox-tdfk
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 26, 2023
Leptomeningeal Tumor, Metastatic Lung Non-Small Cell Carcinoma, Metastatic Malignant Tumor in the Brain Trial in United States
Recruiting
- Leptomeningeal Neoplasm
- +6 more
- Sapanisertib
- Telaglenastat Hydrochloride
-
Duarte, California
- +6 more
Dec 29, 2022
Primary Systemic Amyloidosis, Light Chain Deposition Disease Trial in United States (drug, genetic, other, procedure)
Active, not recruiting
- Primary Systemic Amyloidosis
- Light Chain Deposition Disease
- bortezomib
- +6 more
-
Denver, Colorado
- +6 more
Aug 24, 2022
Allergic Rhinitis Trial in Taichung, Tainan, Taipei (azelastine/fluticasone 137/50 mcg nasal spray, Dymista™)
Completed
- Allergic Rhinitis
- azelastine/fluticasone 137/50 mcg nasal spray
- Dymista™
-
Taichung, Taiwan
- +4 more
Sep 20, 2023
Lymphoma, Lymphoma, B-Cell, Lymphoma, T-Cell Trial in New York (Pharmacokinetics)
Recruiting
- Lymphoma
- +4 more
- Pharmacokinetics
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Sep 12, 2022